Strokes and Heart Attacks Kill. New Drugs Are Coming to Prevent Them. - Barron's
1. Eli Lilly is involved in developing new cholesterol-lowering drugs. 2. New cardiovascular drugs may generate billions in revenue for companies. 3. Merck is testing a pill for cholesterol, potentially impacting market competition. 4. Gene-editing therapies could revolutionize cholesterol management, including partnerships with Lilly. 5. Current PCSK9 drugs face challenges; successes may benefit Lilly's portfolio.